MSFT
Microsoft Corporation
MSFT has the edge over XRX overall, supported by lower modeled downside and stronger fundamentals.
XRX
Xerox Holdings Corporation
XRX's outlook is improving, though it still trails on the overall score.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
XRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
XRX's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
XRX PE Valuation
XRX has no meaningful PE right now: it lost money over the past year.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
XRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect XRX's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over XRX on earnings quality, reporting a profit while its opponent remains loss making.
XRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$9.12 | -$1.28 |
| Q2 2026 | -$7.40 | +$4.14 |
| Q1 2026 | -$8.34 | +$2.22 |
| Q4 2025 | -$8.25 | +$2.50 |
| Q3 2025 | -$7.84 | +$3.09 |
| Q2 2025 | -$11.54 | -$10.60 |
| Q1 2025 | -$10.56 | -$9.10 |
| Q4 2024 | -$10.75 | -$10.66 |
XRX is still losing money, but less than at its worst: $9.12 per share over the past year, against $11.54 at its worst in mid-2025.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over XRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over XRX on profitability, with a higher operating margin.
XRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | -4.7% |
| Q2 2026 | $1.9B | +22% |
| Q1 2026 | $1.8B | +27% |
| Q4 2025 | $2B | +26% |
| Q3 2025 | $2B | +28% |
| Q2 2025 | $1.6B | -0.1% |
| Q1 2025 | $1.5B | -3% |
| Q4 2024 | $1.6B | -8.6% |
XRX's revenue has picked up after three years of holding roughly level: $1.9B last quarter, down 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -54% | -39 points |
| Q2 2026 | 1.6% | +5.4 points |
| Q1 2026 | -4% | +0.6 points |
| Q4 2025 | -3% | -2.8 points |
| Q3 2025 | -15% | +56 points |
| Q2 2025 | -3.8% | -5.4 points |
| Q1 2025 | -4.6% | +5.4 points |
| Q4 2024 | -0.3% | +4.7 points |
XRX's operating margin was −54% last quarter, down 39 points from the same quarter a year ago, near the bottom of its range since 2019.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over XRX on cash flow, with more consistent year-over-year improvement.
XRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17M | -84% |
| Q2 2026 | $23M | +$38M |
| Q1 2026 | -$156M | -$62M |
| Q4 2025 | $192M | -45% |
| Q3 2025 | $104M | -3.7% |
| Q2 2025 | -$15M | -113% |
| Q1 2025 | -$94M | -$7M |
| Q4 2024 | $346M | -9.2% |
XRX still generates free cash flow, though less than at its 2019 peak: $76M over the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over XRX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
XRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +750K shares |
| 1 year | +3.7% | +4.7M shares |
| 3 years | -16% | -25.5M shares |
| 5 years | -27% | -47.8M shares |
| Available history | -44% | -102M shares |
XRX has 132M diluted shares, up 3.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $3M |
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over XRX on leverage, with a lower net debt burden relative to earnings.
XRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 304.8x | High |
| Q2 2024 | 28.6x | High |
| Q4 2023 | 9.8x | High |
| Q3 2023 | 4.8x | High |
| Q2 2023 | 97.1x | High |
| Q1 2023 | 19.8x | High |
| Q3 2021 | 2.1x | Moderate |
| Q2 2021 | 2.0x | Moderate |
XRX's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
XRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 2.0 | Oversold |
XRX's weekly RSI is 28 (oversold) and its Stochastic is 2 (oversold).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
XRX PE vs Technology Sector
| Metric | XRX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
XRX has no meaningful PE right now: it lost money over the past year.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over XRX on trend strength, trading above more of its moving averages.
XRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.21 | 55% below |
| 20 week MA | $2.70 | 63% below |
| 50 week MA | $2.48 | 60% below |
| 100 week MA | $3.87 | 74% below |
| 200 week MA | $9.05 | 89% below |
XRX is in a downtrend: it's below all five of its weekly moving averages, and 89% below its 200-week average.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over XRX on returns for 2026, with the stronger performance.
XRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.3 | $22.6 | -39% |
| 2021 | $22.6 | $22.5 | -0.6% |
| 2022 | $22.5 | $14.6 | -35% |
| 2023 | $14.6 | $18.3 | +25% |
| 2024 | $18.3 | $9.15 | -50% |
| 2025 | $9.15 | $2.49 | -73% |
| 2026 YTD | $2.49 | $0.99 | -60% |
XRX has finished lower in five of the last six years. It's down 60% so far in 2026.